Trader Alert: Unusual Volume Spotted in Huntsman Corporation (NYSE:HUN)

Share

Nationwide Fund Advisors invested in 0% or 1,926 shares.

Huntsman Corporation has a consensus outperform rating from 9 Wall Street analysts, and the number of shares now sold short amount to at least 3.07% of shares outstanding. It was reported on Oct, 12 by Barchart.com. The stock of Huntsman Corporation (NYSE:HUN) has "Buy" rating given on Tuesday, September 19 by UBS.

Artal Group Sa increased Tesaro Inc (Call) (TSRO) stake by 253.92% reported in 2017Q2 SEC filing. The Artal Group Sa holds 235,000 shares with $32.87 million value, up from 66,400 last quarter. It is 0.00% or $0 reaching $33.2 per share. About 147,964 shares traded. Juno Therapeutics Inc (NASDAQ:JUNO) has declined 39.85% since October 13, 2016 and is downtrending. It has outperformed by 75.18% the S&P500.

Since May 31, 2017, it had 2 buys, and 0 insider sales for $297,682 activity. The average revenue per share growth rate of Huntsman Corporation during the past 12 months was -0.5 percent. The California-based Karp Management Corp has invested 0.15% in Huntsman Corporation (NYSE:HUN). The company has market cap of $304.50 million. Instinet restated a "buy" rating and issued a $30.00 target price on shares of Huntsman Corporation in a research report on Sunday, July 9th. Goldman Sachs initiated Juno Therapeutics Inc (NASDAQ:JUNO) on Wednesday, November 18 with "Neutral" rating. On Tuesday, May 30 the stock rating was maintained by Jefferies with "Buy". The rating was maintained by Jefferies with "Buy" on Monday, August 28. The firm earned "Overweight" rating on Thursday, October 15 by KeyBanc Capital Markets. Huntsman Corporation (HUN) has made its way to a 12-month gain of 73.45%. They expect $0.43 earnings per share, up 13.16% or $0.05 from last year's $0.38 per share. Whittier Tru Of Nevada holds 0% of its portfolio in Huntsman Corporation (NYSE:HUN) for 300 shares.

Investors sentiment increased to 1.06 in 2017 Q2. Its up 0.16, from 0.9 in 2017Q1. It is positive, as 47 investors sold HUN shares while 98 reduced holdings. 62 funds opened positions while 91 raised stakes. Tradewinds Mngmt Limited Liability Com holds 0% of its portfolio in Juno Therapeutics Inc (NASDAQ:JUNO) for 28 shares. Ubs Asset Americas owns 342,713 shares or 0% of their United States portfolio. Td Asset Management Incorporated stated it has 26,051 shares or 0% of all its holdings. Agf Invests reported 45,237 shares. Howe Rusling Incorporated has 360 shares. Huntsman Corporation earned a news impact score of 0.25 on Accern's scale. Lourd Ltd accumulated 10,956 shares.

In other news, insider Jon M. Huntsman sold 100,000 shares of the firm's stock in a transaction dated Monday, April 3rd. Huntsman Corporation has $34.0 highest and $0 lowest target. The Broadfin Capital Llc holds 262,100 shares with $7.83M value, up from 175,700 last quarter. Profund Advsrs Limited Liability Co holds 0.01% or 10,494 shares in its portfolio. FMR LLC now owns 892,871 shares of the basic materials company's stock worth $17,036,000 after buying an additional 732,885 shares during the period. Pacad Invest Limited holds 0.01% or 1,400 shares. Mckinley Cap Management Limited Liability Delaware has invested 0% in Huntsman Corporation (NYSE:HUN). The company has market cap of $6.57 billion. The Company operates all of its businesses through its subsidiary, Huntsman International LLC (Huntsman International). It has a 16.22 P/E ratio. The Company operates through five segments: Polyurethanes, Performance Products, Advanced Materials, Textile Effects, and Pigments and Additives. It also upped Coca Cola Co (NYSE:KO) stake by 90,400 shares and now owns 366,200 shares.

Investors sentiment increased to 3.86 in 2017 Q2. Its up 1.03, from 0.64 in 2017Q1. It improved, as 21 investors sold JUNO shares while 40 reduced holdings. 500.06 million shares or 0.04% more from 499.87 million shares in 2017Q1 were reported. Swift Run Capital Ltd Llc has invested 7.93% in Huntsman Corporation (NYSE:HUN). Summit Securities Gp Limited invested 0.04% of its portfolio in Huntsman Corporation (NYSE:HUN). After having $0.85 EPS previously, Huntsman Corporation's analysts see -49.41% EPS growth. Ardsley Advisory reported 0.05% in Juno Therapeutics Inc (NASDAQ:JUNO). National Bank Of America De owns 111,326 shares. Tiaa Cref Inv Management Ltd Liability holds 0% of its portfolio in Old Point Financial Corporation (NASDAQ:OPOF) for 8,836 shares.

Broadfin Capital Llc decreased Heron Therapeutics Inc (Call) (NASDAQ:HRTX) stake by 4.65M shares to 300,900 valued at $4.17M in 2017Q2. Jpmorgan Chase holds 0% or 113,124 shares. Comerica Comml Bank has 0.01% invested in Huntsman Corporation (NYSE:HUN). Hbk Lp, a Texas-based fund reported 14,757 shares. Freestone Ltd Limited Liability Company reported 358,177 shares stake.

Huntsman Corporation was covered by a number of analysts recently, 3 rated the stock as Buy, 6 rated Outperform, 0 rated Hold, 0 gave an Underperform and 0 rated sell. Therefore 53% are positive. Prologis had 50 analyst reports since July 22, 2015 according to SRatingsIntel. BTIG Research upgraded the stock to "Hold" rating in Monday, August 28 report. The ex-dividend date is Tuesday, June 13th. Stifel Nicolaus maintained Prologis Inc (NYSE:PLD) on Wednesday, January 27 with "Buy" rating. As per Wednesday, April 27, the company rating was maintained by Barclays Capital. The company was maintained on Tuesday, May 3 by Nomura. Stifel Nicolaus maintained Prologis Inc (NYSE:PLD) on Tuesday, July 4 with "Buy" rating.

Analysts await Prologis Inc (NYSE:PLD) to report earnings on October, 19. They expect $0.43 earnings per share, up 13.16% or $0.05 from last year's $0.38 per share. PLD's profit will be $352.10M for 24.50 P/E if the $0.66 EPS becomes a reality. The basic materials company reported $0.85 EPS for the quarter, beating the Zacks' consensus estimate of $0.67 by $0.18.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Share